Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_assertion type Assertion NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_head.
- NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_assertion description "[These results suggest that OCIAD2 begins to express at the progression from in situ to invasive carcinoma, and is associated with the favorable prognosis of adenocarcinoma mixed subtype with BAC component.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_provenance.
- NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_assertion evidence source_evidence_literature NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_provenance.
- NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_assertion SIO_000772 17054434 NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_provenance.
- NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_assertion wasDerivedFrom befree-20140225 NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_provenance.
- NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_assertion wasGeneratedBy ECO_0000203 NP718363.RAvYwmTe8lL-9KQvkEgllk8qmCWyXEozSI4Xs0uUnyl-I130_provenance.